Zolgensma (onasemnogene abeparvovec)

pCPA File Number: 21392
Negotiation Status:
Active Negotiation
Indication(s):
Spinal Muscular Atrophy
Sponsor/Manufacturer:
Novartis Pharmaceuticals Canada Inc.
CADTH Project Number:
SG0649-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable